Cargando…

Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19

A detailed understanding of the molecular mechanism of SARS-CoV-2 pathogenesis is still elusive, and there is a need to address its deadly nature and to design effective therapeutics. Here, we present a study that elucidates the interplay between the SARS-CoV and SARS-CoV-2 viruses' and host�...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Md. Abdullah-Al-Kamran, Sany, Md. Rabi Us, Islam, Md. Shafiqul, Islam, Abul Bashar Mir Md. Khademul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381279/ https://www.ncbi.nlm.nih.gov/pubmed/32765592 http://dx.doi.org/10.3389/fgene.2020.00765

Ejemplares similares

SARS-CoV-2 mutations altering regulatory properties: Deciphering host's and virus's perspectives
por: Islam, Abul Bashar Mir Md. Khademul, et al.
Publicado: (2021)

SARS-CoV-2 Proteins Exploit Host’s Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways
por: Khan, Md. Abdullah-Al-Kamran, et al.
Publicado: (2021)

Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2
por: Islam, Abul Bashar Mir Md. Khademul, et al.
Publicado: (2021)

Perversely expressed long noncoding RNAs can alter host response and viral proliferation in SARS-CoV-2 infection
por: Turjya, Rafeed Rahman, et al.
Publicado: (2020)

Targeting SARS-CoV-2 non-structural protein 13 via helicase-inhibitor-repurposing and non-structural protein 16 through pharmacophore-based screening
por: Samdani, Md. Nazmus, et al.
Publicado: (2022)

Molecular Epidemiology of SARS-CoV-2 in Diverse Environmental Samples Globally
por: Islam, Ariful, et al.
Publicado: (2021)

Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches
por: Ahmed, Fee Faysal, et al.
Publicado: (2022)

Newly designed analogues from SARS-CoV inhibitors mimicking the druggable properties against SARS-CoV-2 and its novel variants
por: Ferdous, Nadim, et al.
Publicado: (2021)

Temporal dynamics and fatality of SARS‐CoV‐2 variants in Bangladesh
por: Rahman, M. Shaminur, et al.
Publicado: (2023)

Olfactory and Taste Disorders in Patients with SARS-CoV-2 Infection
por: Begam, Nazia, et al.
Publicado: (2020)

Escalating SARS-CoV-2 circulation in environment and tracking waste management in South Asia
por: Islam, Ariful, et al.
Publicado: (2021)

The role of vitamin D in reducing SARS-CoV-2 infection: An update
por: Shah Alam, Mohammad, et al.
Publicado: (2021)

Potential antiviral peptides against the nucleoprotein of SARS-CoV-2
por: Mahdi, Iktedar, et al.
Publicado: (2022)

B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV
por: Scheid, Johannes F., et al.
Publicado: (2021)

Mutational insights into the envelope protein of SARS-CoV-2
por: Rahman, M. Shaminur, et al.
Publicado: (2021)

The impact of mucormycosis (black fungus) on SARS-CoV-2-infected patients: at a glance
por: Islam, Md. Rezaul, et al.
Publicado: (2022)

Glossary of phytoconstituents: Can these be repurposed against SARS CoV-2? A quick in silico screening of various phytoconstituents from plant Glycyrrhiza glabra with SARS CoV-2 main protease
por: Hejazi, Iram Iqbal, et al.
Publicado: (2021)

Crippling SARS-CoV-2 vaccine supply crunch, vaccination target and scope in Bangladesh
por: Islam, Md. Samiul, et al.
Publicado: (2021)

Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and Cannabis sativa: A Comprehensive Review
por: Mahmud, Md Sultan, et al.
Publicado: (2021)

Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
por: Goyal, Rajat, et al.
Publicado: (2022)

Functional Analysis of Hypothetical Proteins of Vibrio parahaemolyticus Reveals the Presence of Virulence Factors and Growth-Related Enzymes With Therapeutic Potential
por: Shahrear, Sazzad, et al.
Publicado: (2022)

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Huh, Jung Eun, et al.
Publicado: (2021)

SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge
por: Ezhilan, Madeshwari, et al.
Publicado: (2021)

A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV
por: Zhou, Huan, et al.
Publicado: (2021)

Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

Potential drug targets of SARS-CoV-2: From genomics to therapeutics
por: Shamsi, Anas, et al.
Publicado: (2021)

SARS-CoV-2 at the human-animal interphase: A review
por: Farag, Elmoubasher A., et al.
Publicado: (2021)

The mysterious origins of the Omicron variant of SARS-CoV-2
por: Du, Pei, et al.
Publicado: (2022)

SARS-CoV-2 in companion animals: Do levels of SARS-CoV-2 seroconversion in pets correlate with those of pet’s owners and with protection against subsequent SARS-CoV-2 infection?
por: Murphy, Hannah, et al.
Publicado: (2022)

Host range projection of SARS-CoV-2: South Asia perspective
por: Ahmed, Rasel, et al.
Publicado: (2021)

SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development
por: de Souza Silva, Guilherme Antonio, et al.
Publicado: (2020)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
por: Abdelghany, T.M., et al.
Publicado: (2021)

Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammals
por: Li, Meng, et al.
Publicado: (2023)

Genome sequence of SARS-CoV-2 sublineage BA.2.12.1 strain from Bangladesh
por: Akram, Arifa, et al.
Publicado: (2022)

Immunoinformatics and molecular modeling approach to design universal multi-epitope vaccine for SARS-CoV-2
por: Khan, Md. Tahsin, et al.
Publicado: (2021)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Petersen, Eskild, et al.
Publicado: (2020)

Correction to: Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vo76i50tlig44u8rat9gq9s7e2